Search

everythinglearnresearchcommunity

for

Search:↓

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Botulinum Toxin Type A delivered through the skin may be a promising treatment for Frontal Fibrosing Alopecia.

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Ondansetron can cause serious allergic reactions, so use it carefully.

Probe detects finasteride with high selectivity and low detection limit.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Using electronic health records can help identify drug side effects but has some limitations.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

The cosmetic product improved melasma and skin quality without causing irritation.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Individualized treatments may help manage Dercum's disease symptoms.

The new face mask with Eflornithine can potentially reduce facial hair growth and moisturize skin.

Etanercept effectively treated a severe skin condition when other treatments failed.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Belimumab effectively controls SLE disease activity and reduces steroid use.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

BMS-470539 reduces skin fibrosis and inflammation.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Combining α1A-blockers with Prozac is more effective for treating premature ejaculation than Prozac alone.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.